Clinical trial
Efficacy of Fixed Combination Therapy of Vildagliptin and Metformin Compared to…
NCT00382096 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00382096 |
|---|---|
| Title | Efficacy of Fixed Combination Therapy of Vildagliptin and Metformin Compared to the Individual Monotherapy Components in Drug Naive Patients With Type 2 Diabetes |
| Official title | A Randomized, Double-blind, Active-controlled, Multicenter Study to Compare the Effect of 24 Weeks Treatment With a Fixed Combination Therapy of Vildagliptin and Metformin to the Individual Monotherapy Components in Drug Naive Patients With Type 2 Diabetes |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Vildagliptin, Metformin, Vildagliptin + Metformin |
| Enrollment | 1,179 |
| Start date | Sep 1, 2006 |
| Primary completion | Jun 3, 2008 |
| Completion | Jun 3, 2008 |
| First posted | Sep 28, 2006 |
| Last update posted | Dec 19, 2020 |
| Countries | Germany, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: